FR2796962B1 - Procede de culture in vitro de virus des familles togaviridae et flaviviridae, lignee cellulaire et utilisations - Google Patents

Procede de culture in vitro de virus des familles togaviridae et flaviviridae, lignee cellulaire et utilisations

Info

Publication number
FR2796962B1
FR2796962B1 FR9910095A FR9910095A FR2796962B1 FR 2796962 B1 FR2796962 B1 FR 2796962B1 FR 9910095 A FR9910095 A FR 9910095A FR 9910095 A FR9910095 A FR 9910095A FR 2796962 B1 FR2796962 B1 FR 2796962B1
Authority
FR
France
Prior art keywords
togaviridae
viruses
cell line
vitro culture
flaviviridae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9910095A
Other languages
English (en)
Other versions
FR2796962A1 (fr
Inventor
Patrice Andre
Vincent Lotteau
Baccala Glaucia Paranhos
Pradel Florence Komurian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Biomerieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9910095A priority Critical patent/FR2796962B1/fr
Application filed by Biomerieux SA filed Critical Biomerieux SA
Priority to AU68474/00A priority patent/AU6847400A/en
Priority to JP2001514083A priority patent/JP2003506031A/ja
Priority to CA002380407A priority patent/CA2380407A1/fr
Priority to PCT/FR2000/002202 priority patent/WO2001009289A1/fr
Priority to EP00956580A priority patent/EP1203076A1/fr
Publication of FR2796962A1 publication Critical patent/FR2796962A1/fr
Application granted granted Critical
Publication of FR2796962B1 publication Critical patent/FR2796962B1/fr
Priority to US10/776,617 priority patent/US20040229336A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24251—Methods of production or purification of viral material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR9910095A 1999-07-30 1999-07-30 Procede de culture in vitro de virus des familles togaviridae et flaviviridae, lignee cellulaire et utilisations Expired - Fee Related FR2796962B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR9910095A FR2796962B1 (fr) 1999-07-30 1999-07-30 Procede de culture in vitro de virus des familles togaviridae et flaviviridae, lignee cellulaire et utilisations
JP2001514083A JP2003506031A (ja) 1999-07-30 2000-07-31 トガウィルス及びフラビウィルス科のウィルスのインビトロ培養方法及び使用
CA002380407A CA2380407A1 (fr) 1999-07-30 2000-07-31 Procede de culture in vitro de virus des familles togaviridae et flaviviridae et applications
PCT/FR2000/002202 WO2001009289A1 (fr) 1999-07-30 2000-07-31 Procede de culture in vitro de virus des familles togaviridae et flaviviridae et applications
AU68474/00A AU6847400A (en) 1999-07-30 2000-07-31 Method for in vitro culture of viruses of the togaviridae and flaviviridae family and uses
EP00956580A EP1203076A1 (fr) 1999-07-30 2000-07-31 Procede de culture in vitro de virus des familles togaviridae et flaviviridae et applications
US10/776,617 US20040229336A1 (en) 1999-07-30 2004-02-12 Method for in vitro culture of viruses of the togaviridae and flaviviridae families and uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9910095A FR2796962B1 (fr) 1999-07-30 1999-07-30 Procede de culture in vitro de virus des familles togaviridae et flaviviridae, lignee cellulaire et utilisations

Publications (2)

Publication Number Publication Date
FR2796962A1 FR2796962A1 (fr) 2001-02-02
FR2796962B1 true FR2796962B1 (fr) 2003-11-21

Family

ID=9548858

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9910095A Expired - Fee Related FR2796962B1 (fr) 1999-07-30 1999-07-30 Procede de culture in vitro de virus des familles togaviridae et flaviviridae, lignee cellulaire et utilisations

Country Status (6)

Country Link
EP (1) EP1203076A1 (fr)
JP (1) JP2003506031A (fr)
AU (1) AU6847400A (fr)
CA (1) CA2380407A1 (fr)
FR (1) FR2796962B1 (fr)
WO (1) WO2001009289A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2840921B1 (fr) 2002-06-18 2008-07-18 Bio Merieux Procede de culture in vitro du virus vhc
FR2909101B1 (fr) 2006-11-24 2009-02-27 Samuel Stremsdoerfer Procede non electrolytique prefectionne de metallisation d'un substrat par voie de reduction de sel(s) metallique(s) et par projection d'aerosol(s)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5679342A (en) * 1987-11-18 1997-10-21 Chiron Corporation Hepatitis C virus infected cell systems
US5552310A (en) * 1992-06-12 1996-09-03 Hiroshi Yoshikura Replication of hepatitis C virus genome and identification of virus having high infectivity
AU6943994A (en) * 1993-05-04 1994-11-21 United States Of America, As Represented By The Secretary, Department Of Health And Human Services Hepatitis c virus cell propagation and related methods
JPH10194988A (ja) * 1997-01-16 1998-07-28 Sumitomo Pharmaceut Co Ltd アポトーシス抑制剤

Also Published As

Publication number Publication date
AU6847400A (en) 2001-02-19
EP1203076A1 (fr) 2002-05-08
FR2796962A1 (fr) 2001-02-02
JP2003506031A (ja) 2003-02-18
CA2380407A1 (fr) 2001-02-08
WO2001009289A1 (fr) 2001-02-08

Similar Documents

Publication Publication Date Title
HK1009980A1 (en) Method for selective inactivation of viral replication
HK1062029A1 (en) Multiplication of viruses in a cell culture
EE200100437A (et) C-21 modifitseeritud epotioloonid, nende valmistamise meetod ning kasutamine
DE895535T1 (de) Grippevirus, repliziert in säugerzellkultur, und impfstoffherstellung
IS6515A (is) Fósturstofnfrumurækt prímata, sem laus er við sermi
GB2391965B (en) Method of, and system for, heuristically detecting viruses in executable code
BR0007065B1 (pt) sistema e método de processamento de sangue e método de processamento de glóbulos vermelhos.
DE60005518D1 (de) Teilchennachweissystem und damit verbundene methoden
DK1224170T3 (da) I 6-position substitueret indolin, fremstilling og anvendelse deraf som lægemiddel
LU92749I2 (fr) Composition comprenant le virus de la diarrhée virale bovine atténué 1(bvdv-1) et le virus de la diarrhée virale bovine atténué 2 (bvdv-2)
NO20004104D0 (no) Preparater omfattende virus og fremgangsmÕter for konsentrering av viruspreparater
EP1462525A4 (fr) Systeme d'expression d'arnsi et procede de production de cellule knockdown a gene fonctionnel ou analogue utilisant ce systeme
ATE365205T1 (de) Virale partikel, die nach infektion durch humanes cytomegalovirus freigesetzt werden und ihre verwendung als impfstoff
MXPA03007535A (es) Metodo para extraer virus de cultivo celular.
FR2816847B1 (fr) Biomateriaux polymeriques poreux, procede de preparation et utilisations
GB9921337D0 (en) Modified plant viruses
ATE519772T1 (de) Vorrichtung und system mit trockener kontrollgen- verstummungszusammensetzung
NO993297D0 (no) Fast dyrkningsmedium for mikroorganismer, fremgangsmÕte for fremstilling herav og anvendelse herav
FR2796962B1 (fr) Procede de culture in vitro de virus des familles togaviridae et flaviviridae, lignee cellulaire et utilisations
EP1250929A4 (fr) Compositions a base de proteines de plasma exemptes de virus traitees a l'aide d'une membrane poreuse et procede de production
DE60040489D1 (de) Aufzugssystem und inspektionsverfahren dafür
DK1237537T3 (da) Præparat i form af en gel til modtagelse af et aktivt stof i oplösning eller suspension, især til anvendelse på en slimhinde, og fremgangsmåde til dets fremstilling
GB0229261D0 (en) Cells,culture methods and their uses
DE60103477D1 (de) Thermisches Übertragungsblatt, thermisches Übertragungsverfahren und thermisches Übertragungssystem
GB0122933D0 (en) High efficiency microbiological disinfection and pollution removal system

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20060331